Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Fechtner

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Glaucoma|June 4, 2015
Effect of age and disc size on rim order rules by Heidelberg Retina TomographNatasha V Nayak, Tamara L Berezina, Robert D Fechtner, et al.
Acta Ophthalmologica Scandinavica|February 26, 2004
Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trialsRobert D Fechtner, P Juhani Airaksinen, Albert J Getson, et al.
European Journal of Ophthalmology|February 1, 2011
Peripheral visual field thresholds using Humphrey Field Analyzer program 60-4 in normal eyesTamara L Berezina, Albert S Khouri, Anton M Kolomeyer, et al.
American Journal of Ophthalmology|September 15, 2004
An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucomaDavid S Friedman, M Roy Wilson, Jeffrey M Liebmann, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 13, 2015
Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort studyCeline E Saade, Hamed B Lari, Tamara L Berezina, et al.
Journal of Glaucoma|April 21, 2004
Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertensionJess T Whitson, Charles Henry, Bret Hughes, et al.
Ophthalmology|January 23, 2009
Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injectionDaniel B Roth, Varun Verma, Tony Realini, et al.
Journal of Glaucoma|July 2, 2016
Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital GlaucomaXintong Li, Lekha Mukkamala, Catherine A Origlieri, et al.
Retina (Philadelphia, Pa.)|July 22, 2014
Combined pars plana vitrectomy and pars plana Baerveldt tube placement in eyes with neovascular glaucomaAnton M Kolomeyer, Christopher W Seery, Parisa Emami-Naeimi, et al.
Cornea|April 14, 2010
Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medicationsRobert D Fechtner, David G Godfrey, Donald Budenz, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Glaucoma|June 4, 2015
Effect of age and disc size on rim order rules by Heidelberg Retina TomographNatasha V Nayak, Tamara L Berezina, Robert D Fechtner, et al.
Acta Ophthalmologica Scandinavica|February 26, 2004
Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trialsRobert D Fechtner, P Juhani Airaksinen, Albert J Getson, et al.
European Journal of Ophthalmology|February 1, 2011
Peripheral visual field thresholds using Humphrey Field Analyzer program 60-4 in normal eyesTamara L Berezina, Albert S Khouri, Anton M Kolomeyer, et al.
American Journal of Ophthalmology|September 15, 2004
An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucomaDavid S Friedman, M Roy Wilson, Jeffrey M Liebmann, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 13, 2015
Topical glaucoma therapy and ocular surface disease: a prospective, controlled cohort studyCeline E Saade, Hamed B Lari, Tamara L Berezina, et al.
Journal of Glaucoma|April 21, 2004
Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertensionJess T Whitson, Charles Henry, Bret Hughes, et al.
Ophthalmology|January 23, 2009
Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injectionDaniel B Roth, Varun Verma, Tony Realini, et al.
Journal of Glaucoma|July 2, 2016
Corneal Haze as Prognostic Indicator of Intraocular Pressure in Primary Congenital GlaucomaXintong Li, Lekha Mukkamala, Catherine A Origlieri, et al.
Retina (Philadelphia, Pa.)|July 22, 2014
Combined pars plana vitrectomy and pars plana Baerveldt tube placement in eyes with neovascular glaucomaAnton M Kolomeyer, Christopher W Seery, Parisa Emami-Naeimi, et al.
Cornea|April 14, 2010
Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medicationsRobert D Fechtner, David G Godfrey, Donald Budenz, et al.
Pageof 5